Targeting Inflammatory Mediators in Epilepsy: A Systematic Review of Its Molecular Basis and Clinical Applications
出版年份 2022 全文链接
标题
Targeting Inflammatory Mediators in Epilepsy: A Systematic Review of Its Molecular Basis and Clinical Applications
作者
关键词
-
出版物
Frontiers in Neurology
Volume 13, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-03-11
DOI
10.3389/fneur.2022.741244
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Rituximab for the treatment of multiple sclerosis: a review
- (2021) Clara Grazia Chisari et al. JOURNAL OF NEUROLOGY
- Multifocal neutrophilic meningoencephalitis: a novel disorder responsive to anakinra
- (2021) Joseph R. Berger et al. JOURNAL OF NEUROLOGY
- The role of inflammatory mediators in epilepsy: Focus on developmental and epileptic encephalopathies and therapeutic implications
- (2021) Alessandro Orsini et al. EPILEPSY RESEARCH
- Links between Immune Cells from the Periphery and the Brain in the Pathogenesis of Epilepsy: A Narrative Review
- (2021) Gaku Yamanaka et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
- (2021) Matthew J. Page et al. International Journal of Surgery
- Super-refractory status epilepticus in autoimmune encephalitis treated with interleukin-1 receptor antagonist, anakinra
- (2021) Chun-ho Choi et al. EPILEPTIC DISORDERS
- Safety and Efficacy of Nataluzimab as Adjunctive Therapy for People With Drug-Resistant Epilepsy: A Phase 2 Study
- (2021) Jacqueline A. French et al. NEUROLOGY
- Tocilizumab in pediatric refractory status epilepticus and acute epilepsy: Experience in two patients
- (2020) Verónica Cantarín-Extremera et al. JOURNAL OF NEUROIMMUNOLOGY
- Seizures and myelin oligodendrocyte glycoprotein (MOG) antibodies: two paradigmatic cases and a review of the literature
- (2020) Foiadelli Thomas et al. Multiple Sclerosis and Related Disorders
- Tumor Necrosis Factor-α, the Pathological Key to Post-Traumatic Epilepsy: A Comprehensive Systematic Review
- (2020) Alina Arulsamy et al. ACS Chemical Neuroscience
- Efficacy and safety of rituximab in autoimmune encephalitis: A meta‐analysis
- (2020) Gaurav Nepal et al. ACTA NEUROLOGICA SCANDINAVICA
- Potential Role of Anti-interleukin (IL)-6 Drugs in the Treatment of COVID-19: Rationale, Clinical Evidence and Risks
- (2020) Salvatore Crisafulli et al. BIODRUGS
- Inflammatory Manifestations of Systemic Diseases in the Central Nervous System
- (2020) David A. Lapides et al. Current Treatment Options in Neurology
- The cat's out of the bag: a rare case of new-onset refractory status epilepticus (NORSE) due to Bartonella henselae
- (2020) Emily Kern-Smith et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Behçet’s Disease in Children: Diagnostic and Management Challenges
- (2020) Giorgio Costagliola et al. Therapeutics and Clinical Risk Management
- HMGB1 in inflammation and cancer
- (2020) Shumin Wang et al. Journal of Hematology & Oncology
- Teratoma Removal, Steroid, IVIG, Rituximab and Tocilizumab (T-SIRT) in Anti-NMDAR Encephalitis
- (2020) Woo-Jin Lee et al. Neurotherapeutics
- Successful treatment of pediatric FIRES with anakinra
- (2020) Jennifer Yang et al. PEDIATRIC NEUROLOGY
- Rasmussen's encephalitis: From immune pathogenesis towards targeted-therapy
- (2020) A. Orsini et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments Committee
- (2020) David G. Vossler et al. Epilepsy Currents
- The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders
- (2020) Paulina Pawelec et al. Cells
- Use of Unconventional Therapies in Super-refractory Status Epilepticus: A Case Report and Literature Review
- (2020) Maria Sole Vallecoccia et al. CLINICAL EEG AND NEUROSCIENCE
- Anakinra usage in febrile infection related epilepsy syndrome: an international cohort
- (2020) Yi‐Chen Lai et al. Annals of Clinical and Translational Neurology
- Linear scleroderma “en coup de sabre” with extensive brain involvement—Clinicopathologic correlations and response to anti-Interleukin-6 therapy
- (2019) Cynthia M. Magro et al. Orphanet Journal of Rare Diseases
- Molecular Mechanism Involved in the Pathogenesis of Early-Onset Epileptic Encephalopathy
- (2019) Giovanna Vitaliti et al. Frontiers in Molecular Neuroscience
- Interleukin-1 causes CNS inflammatory cytokine expression via endothelia-microglia bi-cellular signaling
- (2019) Ling Zhu et al. BRAIN BEHAVIOR AND IMMUNITY
- Relapse risk factors in anti‐N‐methyl‐D‐aspartate receptor encephalitis
- (2019) Margherita Nosadini et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Centromedian thalamic nuclei deep brain stimulation and Anakinra treatment for FIRES – Two different outcomes
- (2019) Mario Sa et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Microglia Biology: One Century of Evolving Concepts
- (2019) Marco Prinz et al. CELL
- Sarilumab: Review of a Second IL-6 Receptor Antagonist Indicated for the Treatment of Rheumatoid Arthritis
- (2018) Eric G. Boyce et al. ANNALS OF PHARMACOTHERAPY
- Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions
- (2018) Lawrence J. Hirsch et al. EPILEPSIA
- Humanized mouse model of Rasmussen’s encephalitis supports the immune-mediated hypothesis
- (2018) Hania Kebir et al. JOURNAL OF CLINICAL INVESTIGATION
- Peripherally derived T regulatory and γδ T cells have opposing roles in the pathogenesis of intractable pediatric epilepsy
- (2018) Dan Xu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Systemic autoinflammation with intractable epilepsy managed with interleukin-1 blockade
- (2018) Allen D. DeSena et al. Journal of Neuroinflammation
- Review: Neuroinflammatory pathways as treatment targets and biomarker candidates in epilepsy: emerging evidence from preclinical and clinical studies
- (2018) E. A. van Vliet et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction
- (2018) Yam Nath Paudel et al. Frontiers in Neuroscience
- Tocilizumab treatment for new onset refractory status epilepticus
- (2018) Jin-Sun Jun et al. ANNALS OF NEUROLOGY
- An evolving redefinition of autoimmune encephalitis
- (2018) Susanna Esposito et al. AUTOIMMUNITY REVIEWS
- The epidemiology of drug-resistant epilepsy: A systematic review and meta-analysis
- (2018) Linda Kalilani et al. EPILEPSIA
- Pearls & Oy-sters: Rheumatoid meningitis occurring during treatment with etanercept
- (2018) Nicoleta Gherghel et al. NEUROLOGY
- Anakinra Therapy for Non-cancer Inflammatory Diseases
- (2018) Giulio Cavalli et al. Frontiers in Pharmacology
- Chemokines as new inflammatory players in the pathogenesis of epilepsy
- (2017) Chiara Cerri et al. EPILEPSY RESEARCH
- Therapeutic effects of anti-HMGB1 monoclonal antibody on pilocarpine-induced status epilepticus in mice
- (2017) Li Fu et al. Scientific Reports
- Tocilizumab (Actemra)
- (2017) Martin Sheppard et al. Human Vaccines & Immunotherapeutics
- Febrile infection-related epilepsy syndrome treated with anakinra
- (2016) Daniel L. Kenney-Jung et al. ANNALS OF NEUROLOGY
- Autoimmune epilepsy
- (2016) Antonio Greco et al. AUTOIMMUNITY REVIEWS
- Anti-tumor necrosis factor alpha therapy (adalimumab) in Rasmussen's encephalitis: An open pilot study
- (2016) Stanislas Lagarde et al. EPILEPSIA
- Neuroinflammation: the devil is in the details
- (2016) Damon J. DiSabato et al. JOURNAL OF NEUROCHEMISTRY
- The Chemokine CCL2 Mediates the Seizure-enhancing Effects of Systemic Inflammation
- (2016) Chiara Cerri et al. JOURNAL OF NEUROSCIENCE
- Inflammatory mediators in human epilepsy: A systematic review and meta-analysis
- (2016) Evelien E. de Vries et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Tocilizumab in Autoimmune Encephalitis Refractory to Rituximab: An Institutional Cohort Study
- (2016) Woo-Jin Lee et al. Neurotherapeutics
- Effect of Immunotherapy on Seizure Outcome in Patients with Autoimmune Encephalitis: A Prospective Observational Registry Study
- (2016) Jung-Ick Byun et al. PLoS One
- Epidemiology of epilepsy
- (2016) C. Behr et al. REVUE NEUROLOGIQUE
- Adult onset Rasmussen’s encephalitis associated with reflex language induced seizures responsive to Rituximab therapy
- (2016) Salwa El Tawil et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- A definition and classification of status epilepticus - Report of the ILAE Task Force on Classification of Status Epilepticus
- (2015) Eugen Trinka et al. EPILEPSIA
- Increased neutralization capacity of TNF-α in sera of relapsing remitting multiple sclerosis patients is not related to soluble TNF-α receptors or anti-TNF-α autoantibody levels
- (2015) Karin Mausner-Fainberg et al. JOURNAL OF NEUROIMMUNOLOGY
- Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability
- (2015) Annamaria Vezzani et al. NEUROPHARMACOLOGY
- Anti-B-Cell Therapies in Autoimmune Neurological Diseases: Rationale and Efficacy Trials
- (2015) Harry Alexopoulos et al. Neurotherapeutics
- Neuroinflammation: Ways in Which the Immune System Affects the Brain
- (2015) Richard M. Ransohoff et al. Neurotherapeutics
- Immunity and Inflammation in Epilepsy
- (2015) Annamaria Vezzani et al. Cold Spring Harbor Perspectives in Medicine
- Drug-Induced Vasculitis: New Insights and a Changing Lineup of Suspects
- (2015) Rafael G. Grau Current Rheumatology Reports
- IL-1 Blockade in Autoinflammatory Syndromes
- (2014) Adriana A. Jesus et al. Annual Review of Medicine
- TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants – past, present and future
- (2014) Lisa M. Sedger et al. CYTOKINE & GROWTH FACTOR REVIEWS
- A validation of the new definition of drug-resistant epilepsy by the International League Against Epilepsy
- (2014) Jose F. Téllez-Zenteno et al. EPILEPSIA
- ILAE Official Report: A practical clinical definition of epilepsy
- (2014) Robert S. Fisher et al. EPILEPSIA
- Long-term remission with rituximab in refractory leucine-rich glioma inactivated 1 antibody encephalitis
- (2014) J. William L. Brown et al. JOURNAL OF NEUROIMMUNOLOGY
- A case of rheumatoid arthritis complicated by demyelination in both cerebral cortex and spinal cord during etanercept therapy
- (2014) Tomohiro Kameda et al. Modern Rheumatology
- Modulating neurotoxicity through CX3CL1/CX3CR1 signaling
- (2014) Cristina Limatola et al. Frontiers in Cellular Neuroscience
- IL-6 in Inflammation, Immunity, and Disease
- (2014) T. Tanaka et al. Cold Spring Harbor Perspectives in Biology
- Relationship Between the Chemokine Receptor CCR5 and Microglia in Neurological Disorders: Consequences of Targeting CCR5 on Neuroinflammation, Neuronal Death and Regeneration in a Model of Epilepsy
- (2013) Jean-Pierre Louboutin et al. CNS & Neurological Disorders-Drug Targets
- Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
- (2013) Maarten J Titulaer et al. LANCET NEUROLOGY
- A complex case of anti-GAD antibody-related syndrome treated with Rituximab
- (2013) D. Baroncini et al. NEUROLOGICAL SCIENCES
- Rasmussen encephalitis treated with natalizumab
- (2013) S. Bittner et al. NEUROLOGY
- An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies
- (2013) Domenica Musumeci et al. PHARMACOLOGY & THERAPEUTICS
- Febrile infection-related epilepsy syndrome: A study of 12 patients
- (2013) Roberto H. Caraballo et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Altered Expression of CX3CL1 in Patients with Epilepsy and in a Rat Model
- (2012) Yali Xu et al. AMERICAN JOURNAL OF PATHOLOGY
- Inflammasomes and Their Roles in Health and Disease
- (2012) Mohamed Lamkanfi et al. Annual Review of Cell and Developmental Biology
- Interleukin-6, a Major Cytokine in the Central Nervous System
- (2012) María Erta et al. International Journal of Biological Sciences
- Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition
- (2012) Luigi Zuliani et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Natalizumab
- (2012) Richard Rudick et al. JAMA Neurology
- Epilepsy and brain inflammation
- (2011) Annamaria Vezzani et al. EXPERIMENTAL NEUROLOGY
- Cytokines and epilepsy
- (2011) Gang Li et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Trafficking of immune cells in the central nervous system
- (2010) Emma H. Wilson et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-1 pathways in inflammation and human diseases
- (2010) Cem Gabay et al. Nature Reviews Rheumatology
- Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies
- (2009) Patrick Kwan et al. EPILEPSIA
- Chemokine CCL2 and its receptor CCR2 are increased in the hippocampus following pilocarpine-induced status epilepticus
- (2009) Maira L Foresti et al. Journal of Neuroinflammation
- A case of Rasmussen encephalitis treated with rituximab
- (2009) Barbara Thilo et al. Nature Reviews Neurology
- TNF-antagonist etanercept induced reversible posterior leukoencephalopathy syndrome
- (2008) O. Kastrup et al. JOURNAL OF NEUROLOGY
- Effect of cytokines on neuronal excitability
- (2008) Maria Schäfers et al. NEUROSCIENCE LETTERS
- Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
- (2007) Daniel Tracey et al. PHARMACOLOGY & THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now